CLASS II ONGOING Drug recall · Reported 24 Jul 2024 · FDA Enforcement Report

Fludrocortisone Acetate Tablets, USP 0.1mg recalled

Teva Pharmaceuticals USA is recalling Fludrocortisone Acetate Tablets, USP 0.1mg, distributed nationwide in the US. The recall was initiated on 28 Jun 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #s: CNSDH, Exp. 6/30/2024; CNWVM, CNWWH, Exp. 07/31/2024; CNXKW, CNXKY, CNXMB, CNXMH, Exp. 09/30/2024; CPBTP, CPBTV, Exp. 11/30/2024.
Quantity recalled116,144 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0601-2024
FDA event ID
94900
Recalling firm
Teva Pharmaceuticals USA, Parsippany, NJ
Classification
Class II
Status
Ongoing
Recall initiated
28 Jun 2024
FDA classified
16 Jul 2024
Reported
24 Jul 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

28 Jun 2024Recall initiated by company
16 Jul 2024Classified by FDA+18 days
24 Jul 2024Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Impurities/Degradation Specifications: Product is being recalled due to API related substances and unknown impurities that are above the specification limits.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Fludrocortisone Acetate Tablets, USP 0.1mg, Rx Only, 100 Tablets per bottle, Manufactured in Canada By: Patheon, Inc., Mississauga, ON, Canada L5N 7K9, Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0555-0997-02.

Where it was distributed

Nationwide in the USA and Puerto Rico

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Failed Impurities/Degradation Specifications: Product is being recalled due to API related substances and unknown impurities that are above the specification limits.

Which lots are affected?

Lot #s: CNSDH, Exp. 6/30/2024; CNWVM, CNWWH, Exp. 07/31/2024; CNXKW, CNXKY, CNXMB, CNXMH, Exp. 09/30/2024; CPBTP, CPBTV, Exp. 11/30/2024.

Where was it sold?

Nationwide in the USA and Puerto Rico

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Teva Pharmaceuticals USA

All 281

Other Fludrocortisone recalls

All 2
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIFludrocortisone Acetate Tablets, USP 0.1mg recalled by AvKAREFludrocortisone AcetateAvKAREPotency & AssayNationwide